GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 94 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $30,000 | +3.4% | 11,809 | -2.1% | 0.00% | 0.0% |
| Q2 2022 | $29,000 | -42.0% | 12,064 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $50,000 | -67.7% | 12,064 | 0.0% | 0.00% | -60.0% |
| Q4 2021 | $155,000 | +19.2% | 12,064 | 0.0% | 0.01% | +11.1% |
| Q3 2021 | $130,000 | +18.2% | 12,064 | 0.0% | 0.01% | +12.5% |
| Q2 2021 | $110,000 | -12.7% | 12,064 | -9.4% | 0.01% | -20.0% |
| Q1 2021 | $126,000 | +12.5% | 13,314 | -53.1% | 0.01% | +11.1% |
| Q4 2020 | $112,000 | +28.7% | 28,380 | -13.3% | 0.01% | +12.5% |
| Q3 2020 | $87,000 | -64.0% | 32,740 | -10.0% | 0.01% | -68.0% |
| Q2 2020 | $242,000 | +160.2% | 36,390 | +127.0% | 0.02% | +127.3% |
| Q1 2020 | $93,000 | -35.4% | 16,030 | 0.0% | 0.01% | -26.7% |
| Q4 2019 | $144,000 | – | 16,030 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $41,970,000 | 8.18% |
| Copernicus Capital Management, LLC | 37,000 | $349,000 | 5.64% |
| EcoR1 Capital, LLC | 3,421,287 | $32,263,000 | 1.43% |
| Palo Alto Investors LP | 2,298,382 | $21,674,000 | 1.24% |
| AlpInvest Partners B.V. | 226,866 | $2,139,000 | 1.06% |
| Stenahm Asset Managment Ltd | 150,000 | $1,415,000 | 1.00% |
| FRAZIER MANAGEMENT LLC | 1,030,878 | $9,721,000 | 0.78% |
| BVF INC/IL | 1,861,239 | $17,551,000 | 0.66% |
| Avidity Partners Management LP | 2,122,064 | $20,011,000 | 0.55% |
| Redmile Group, LLC | 2,448,158 | $23,086,000 | 0.32% |